Swift Biosciences Inc - Medical Equipment - Deals and Alliances Profile
November 2018
35
About the Report
About the Report
Summary
Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company's products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA library kit, comprehensive TP53 panel, 56G oncology panel, EGFR pathway panel and sample ID panel, among others. It develops technologies to examine disease-related genes, improve next generation sequencing sample preparation for illumina and ion torrent platforms, and accelerate sample preparation for DNA sequencing and deliver more usable data from next gen sequencing instruments. The company's products finds application in circulating cell free DNA and tumor cells, amplicon sequencing, bisulfite sequencing, molecular identifiers, hybridization capture sequencing, whole genome sequencing, metagenomics, and others. Swift Biosciences is headquartered in Ann Arbor, Michigan, the US.
Swift Biosciences Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Swift Biosciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Swift Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Swift Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Swift Biosciences Raises USD12.2 Million in Venture Financing 10
Swift Biosciences Raises USD3.3 Million in Venture Financing 11
Swift Biosciences Raises USD1.5 Million in Venture Financing 12
Swift Biosciences Raises USD 7 Million In Series B Financing 13
Swift Biosciences Raises USD 0.8 Million In Series A-1 Financing Round 14
Swift Biosciences Raises USD 0.5 Million In Venture Financing 15
Partnerships 16
Swift Biosciences Enters Into Licensing Agreement With Vela Diagnostics For Cancer Detection Technology 16
Swift Biosciences and Genomenon Enter into Partnership 17
Silicon Biosystems Menarini and Swift Biosciences Enter into Partnership 18
Sophia Genetics Enters into Agreement with Swift Biosciences 19
Swift Biosciences Partners with SeraCare Life Sciences 20
Swift Biosciences Inc-Key Competitors 21
Swift Biosciences Inc-Key Employees 22
Swift Biosciences Inc-Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Strategy And Business Planning 24
Oct 05, 2017: Swift Biosciences Growth Sparks Expansion into New Headquarters & First West Coast Office 24
Corporate Communications 25
May 23, 2018: Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO 25
Jun 29, 2017: Swift Biosciences adds two new Directors to Board 26
Feb 09, 2017: Swift Biosciences Expands Team, Hires Vice President of Marketing 27
Product News 28
Apr 06, 2018: Swift Biosciences Launches Unique Dual Indexing Kits to improve Multiplexed Next Generation Sequencing 28
Oct 12, 2017: Swift Launches Accel-Amplicon Custom NGS Panels, Accelerating Variant Discovery In Challenging Biological Samples 29
Aug 10, 2017: Swift Announces the Highest Throughput Single-Cell Methyl-Seq Library Preparation Method 30
Aug 03, 2017: Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run 31
Mar 22, 2017: Swift Biosciences Launches New Assay for Faster, More Efficient Routine Screening of the CFTR Gene 32
Feb 14, 2017: Swift Biosciences Launches Novel Long-Insert Library Kit to Improve Data Quality on PacBio Sequencing Platforms 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Figure
List of Figures
Swift Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Swift Biosciences Inc, Medical Equipment, Key Facts 2
Swift Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Swift Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Swift Biosciences Raises USD12.2 Million in Venture Financing 10
Swift Biosciences Raises USD3.3 Million in Venture Financing 11
Swift Biosciences Raises USD1.5 Million in Venture Financing 12
Swift Biosciences Raises USD 7 Million In Series B Financing 13
Swift Biosciences Raises USD 0.8 Million In Series A-1 Financing Round 14
Swift Biosciences Raises USD 0.5 Million In Venture Financing 15
Swift Biosciences Enters Into Licensing Agreement With Vela Diagnostics For Cancer Detection Technology 16
Swift Biosciences and Genomenon Enter into Partnership 17
Silicon Biosystems Menarini and Swift Biosciences Enter into Partnership 18
Sophia Genetics Enters into Agreement with Swift Biosciences 19
Swift Biosciences Partners with SeraCare Life Sciences 20
Swift Biosciences Inc, Key Competitors 21
Swift Biosciences Inc, Key Employees 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.